(2) when he expects the revised prostate cancer risk management programme to be published;
(3) what plans he has to (a) monitor and (b) evaluate the use of the revised prostate cancer risk management programme by GPs.
A comprehensive strategy has been developed to inform general practitioners (GPs) of the revised prostate cancer risk management programme (PCRMP) when it is relaunched in summer 2009. This includes:
a medical press launch;
proactive educational programmes;
development of a slide set;
a road show using the slide set, co-ordinated by the British Association of Urological Surgeons;
a web cast;
making the PCRMP materials available on GP information technology systems;
a peer reviewed paper in a peer reviewed journal; and
a British Medical Journal e-learning module.
The Cancer Research UK Primary Care Education Research Group will undertake a detailed evaluation of the use and effectiveness of the revised PCRMP packs, as they did with the original packs.